U&I Corporation (056090) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.034x

Based on the latest financial reports, U&I Corporation (056090) has a cash flow conversion efficiency ratio of -0.034x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.27 Billion ≈ $-2.21 Million USD) by net assets (₩94.87 Billion ≈ $64.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 056090 stock market capitalisation for the company's overall valuation and market capitalisation.

U&I Corporation - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how U&I Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. View U&I Corporation stock price for real-time trading data and today's change.

U&I Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of U&I Corporation ranked by their cash flow conversion efficiency. Review U&I Corporation (056090) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Company Cash Flow Conversion Efficiency
OPUS GLOBAL Nyrt
BUD:OPUS
0.135x
Gray Television Inc
NYSE:GTN
0.005x
THONBURI HEALTHCARE GRO-NVDR
BK:THG-R
N/A
ARS Pharmaceuticals, Inc
NASDAQ:SPRY
-0.381x
Shahe Industry Co Ltd
SHE:000014
-0.065x
Voxel S.A.
WAR:VOX
0.072x
Yulon Nissan Motor Co Ltd
TW:2227
-0.012x
John Wiley & Sons B
NYSE:WLYB
0.185x

Annual Cash Flow Conversion Efficiency for U&I Corporation (2015–2025)

The table below shows the annual cash flow conversion efficiency of U&I Corporation from 2015 to 2025. Also see 056090 current and non-current assets for a full breakdown of the balance sheet.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩94.15 Billion
≈ $63.80 Million
₩2.61 Billion
≈ $1.77 Million
0.028x +59.39%
2024-12-31 ₩86.77 Billion
≈ $58.80 Million
₩1.51 Billion
≈ $1.02 Million
0.017x +142.08%
2023-12-31 ₩59.90 Billion
≈ $40.59 Million
₩-2.48 Billion
≈ $-1.68 Million
-0.041x +55.52%
2022-12-31 ₩57.68 Billion
≈ $39.09 Million
₩-5.36 Billion
≈ $-3.64 Million
-0.093x -306.66%
2021-12-31 ₩28.54 Billion
≈ $19.34 Million
₩1.28 Billion
≈ $870.63K
0.045x -43.30%
2020-12-31 ₩27.09 Billion
≈ $18.36 Million
₩2.15 Billion
≈ $1.46 Million
0.079x +242.79%
2019-12-31 ₩37.99 Billion
≈ $25.74 Million
₩-2.11 Billion
≈ $-1.43 Million
-0.056x +26.25%
2018-12-31 ₩39.20 Billion
≈ $26.57 Million
₩-2.95 Billion
≈ $-2.00 Million
-0.075x -165.54%
2017-12-31 ₩54.29 Billion
≈ $36.79 Million
₩-1.54 Billion
≈ $-1.04 Million
-0.028x +52.66%
2016-12-31 ₩59.07 Billion
≈ $40.03 Million
₩-3.54 Billion
≈ $-2.40 Million
-0.060x +14.63%
2015-12-31 ₩62.85 Billion
≈ $42.59 Million
₩-4.41 Billion
≈ $-2.99 Million
-0.070x --

About U&I Corporation

KQ:056090 Korea Medical Devices
Market Cap
$419.86 Million
₩619.55 Billion KRW
Market Cap Rank
#13261 Global
#397 in Korea
Share Price
₩6000.00
Change (1 day)
-1.64%
52-Week Range
₩864.00 - ₩6100.00
All Time High
₩6100.00
About

CG MedTech Co.,Ltd. researches, develops, manufactures, and sale of orthopedic medical devices in the healthcare service market. The company offers headless screws, cortex screws, and K-wires and pin; Aspiron and Maxima anterior cervical plate systems for use in anterior interbody screw/plate fixation of the cervical spine; ANAX OCT spinal system, a device for spinal surgery; Velofix PEEK SA cerv… Read more